InvestorsHub Logo
Followers 1
Posts 272
Boards Moderated 0
Alias Born 01/24/2004

Re: None

Wednesday, 03/31/2004 7:08:40 PM

Wednesday, March 31, 2004 7:08:40 PM

Post# of 358480
Everone with CMKX stock, please read!

This is a very important pr put out today by LBTT. Please read it.



LBTT News

Lifeline Recognizes Slow Down by Market Makers in Processing Buy Orders in the Company's Stock
09:01 a.m. 03/31/2004 Provided by


LAS VEGAS, Mar 31, 2004 (BUSINESS WIRE) -- Dr. William Reeves, President and founder of Lifeline Biotechnologies, Inc. (LBTT) expressed, once again, total frustration with illegal public trading activity in the Company's common stock.

Dr. Reeves stated, "I was reluctant to issue this release because of its negative content, especially at a time when our company has so many positive activities going on; in fact, more positive activities now than at any previous period in its history. We are currently working on marketing initiatives in both the U.S. and Europe and anticipate several press releases covering these developments; including the favorable results of our recent conferences and conventions, product sales projections and the status of our recent funding efforts. But, unfortunately, this matter needs to be dealt with today taking us away from so many of our important business activities."

In a news release issued in September 2003, Dr. Reeves outlined the negative impact illegal short selling has had on the Company's stock. Since then, Lifeline, its management, and numerous investor supporters have been active, together with many others, in helping bring about new regulations issued by the SEC and NASD to protect investors from illegal short selling.

Reeves stated: "Now that these new rules are scheduled to become effective April 1st, a number of the market makers in the Company's stock are ignoring and/or refusing to process buy orders with the apparent intent to hold down the price per share so short positions can be covered at lower prices. This is illegal activity and management of the company and our legal counsel are in touch with the SEC, NASD, the DTC and the compliance departments of the market makers involved to get this resolved.

"There appears to be a well organized freeze in place by major Pink Sheet market makers to not process buy orders at the market. This is not limited to Lifeline, but is also in play for numerous other stocks that suffer from large illegal short positions.

"We are asking every investor, both new and old, to report each and every holdup to the SEC and NASD compliance, and the compliance department of the broker involved. The regulators do not always respond promptly to these situations, but we believe if they receive calls from all who are affected by this illegal activity, they will force the market makers to process all orders in a legal and orderly fashion.

"Everyone who issues a buy order should also demand that their broker send them their shares and every order that is not processed needs to be reported to the SEC, NASD and the compliance department at the subject brokerage firm."



CONTACT INFORMATION FOR FILING A COMPLAINT:
------------------------------------------

HOWARD CAROLAN Tel: 202-942-4558
STEPHEN CUTTER (Director of Enforcement) Tel: 202-942-4500
NASD CUSTOMER COMPLAINTS:
PATRICIA CLEM Tel: 240-386-4997
DEPOSITORY TRUST COMPANY (DTC) Tel: 212-855-5205
MARKET MAKERS AND SHORT SELLERS:
SCHWAB CAPITAL (SCHB) Tel: 201-963-9100
KNIGHT SEC. (NITE) Tel: 800-232-3684
HILL THOMPSON (HILL) Tel: 201-369-2931
(Pat Brake, Compliance Dept.)
WIEN SECURITIES (WIEN) Tel: 800-624-0050
GVRC CO. (GVRC) Tel: 800-638-8602
T. D. WATERHOUSE (VFIN) Tel: 800-934-4448
A. G. EDWARDS (AGE) Tel: 877-835-7877


On a more positive note, Reeves indicated that Company management is in Las Vegas to attend the Breast Surgeons Conference March 31st through April 3rd. Lifeline will be introducing its newly developed microendoscope known as Mastascope(TM). The Mastascope(TM) is targeted for use by physicians in examining patients with nipple discharge. Management believes, and previous testing of this product indicates, that breast cancer can be detected at a very early stage when treatment is most likely to produce increased levels of success. Dr. Kefah Mokbel, Lifeline's key investigator who assisted in the development of the Mastascope(TM), has stated he believes many needless surgeries could be eliminated by the physician's utilization of this product.

Lifeline's website address: www.lbti.com

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In particular, when used in the preceding discussion, the words "believe," "expects," "projects," "forecasts," "intends," "will," "anticipated," "could," or "may," and similar conditional expressions are intended to identify forward-looking statements within the meaning of the act and subject to the safe harbor created by the act. Except for historical information, all of the statements contained in the foregoing are forward-looking statements that involve a number of risks and uncertainties.


Jim Holmes, 775-324-1933
jholmes@lbti.com
or
Stock Enterprises
Investor Relations
Jim Stock, 866-242-2405
stockenter@aol.com



Get breaking news from companies and organizations worldwide.
Logon for FREE today at www.BusinessWire.com .


Copyright (C) 2004 Business Wire. All rights reserved.


Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.